Stock listing

NASDAQ:PGNX Progenics Pharmaceuticals Inc Stock

Follow Progenics Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PGNX

$4.10 USD

Close on Jun 22, 2020 · No longer trades

Nov 19, 1997 to last close -49.1% · monthly closes, Nov 19, 1997 – Jun 22, 2020
Lowest – highest close
$1.52 – $93.50 USDSince Nov 19, 1997 · lowest Nov 12, 2012 · highest Feb 28, 2000

Delisted NASDAQ:PGNX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PGNX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Progenics Pharmaceuticals Inc on 6ix

Decks
14 decks · latest May 12, 2020

Decks

DeckKindSlidesDate
Merger or Acquisition (May 2020)Merger or acquisition29 slidesMay 12, 2020
Proxy Contest (October 2019)Proxy contest56 slidesOct 30, 2019
Proxy Contest (October 2019)Proxy contest21 slidesOct 23, 2019
Proxy Contest (October 2019)Proxy contest43 slidesOct 22, 2019
Proxy Contest (October 2019)Proxy contest162 slidesOct 21, 2019
Merger or Acquisition (October 2019)Merger or acquisition16 slidesOct 2, 2019
Proxy Contest (June 2019)Proxy contest23 slidesJun 25, 2019
Proxy Contest (June 2019)Proxy contest8 slidesJun 24, 2019
Proxy Contest (June 2019)Proxy contest56 slidesJun 21, 2019
Proxy Contest (June 2019)Proxy contest58 slidesJun 20, 2019
All 14 decks
DeckKindSlidesDate
Jefferies Healthcare Conference 2019Conference30 slidesJun 6, 2019
Investor Presentation (January 2019)Investor deck28 slidesJan 4, 2019
Investor Presentation (January 2018)Investor deck31 slidesJan 8, 2018
Technical Presentation (June 2017)Technical40 slidesJun 20, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Hagop Youssoufian
Other companies: BIND Therapeutics Inc (CHIEF MEDICAL OFFICER · Nov 1, 2014 – Mar 7, 2015 · Past); Alaunos Therapeutics, Inc. (President of R&D and CMO · Jul 15, 2011 – Dec 31, 2012 · Past)
Executive Vice President R&D · Aug 1, 2013 – Mar 3, 2014 · Past
Michael D Kishbauch
Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2016); Achillion Pharmaceuticals Inc (Director · Jan 25, 2016 – Jan 28, 2020 · Past)
Director · Jun 8, 2016 – Jul 11, 2019 · Past
Ann L MacDougall
Other companies: Opiant Pharmaceuticals Inc (Director · Jun 12, 2019 – Mar 2, 2023 · Past)
Director · Dec 13, 2019 – Jun 19, 2020 · Past
Asha Das
Other companies: Tocagen Inc (SVP & Chief Medical Officer · Apr 12, 2017 – Mar 1, 2018 · Past)
Chief Medical Officer · Jan 2, 2019 – Jun 19, 2020 · Past
David A. Scheinberg
Other companies: SELLAS Life Sciences Group, Inc. (Director · Since at least Dec 29, 2017)
Director · Jan 24, 2006 – Jul 11, 2019 · Past
Heinz Christoph Maeusli
Other companies: Lantheus Holdings, Inc. (Director · Since at least Jun 19, 2020)
Director · Dec 13, 2019 – Jun 19, 2020 · Past
Kurt W Briner
Other companies: BioAmber Inc (BIOA) (Director · Aug 15, 2013 – Aug 15, 2017 · Past)
Director · Feb 3, 2012 – Jun 13, 2012 · Past
Nicole Williams
Other companies: Intercept Pharmaceuticals Inc (Director · Jul 20, 2015 – Nov 20, 2015 · Past)
Director · Jun 8, 2016 – Jul 11, 2019 · Past
Vivien Wong
Other companies: Cyclo Therapeutics Inc (Director · Aug 17, 2023 – Feb 27, 2025 · Past)
EVP, Development · Apr 1, 2015 – Jun 19, 2020 · Past
Angelo William Lovallo JrVice President Finance · Apr 9, 2013 – Mar 2, 2015 · Past
All 15 people
PersonSeat
Bryce TenbargeSVP, Commercial · Aug 22, 2016 – Jun 19, 2020 · Past
David W MimsInterim CEO and Interim CFO, Director · Dec 13, 2019 – Jun 19, 2020 · Past
Paul J MaddonDirector · Apr 22, 2016 – Apr 22, 2016 · Past
Peter J CrowleyDirector · Jun 26, 2019 – Jul 11, 2019 · Past
Robert A McKinneySenior VP, CFO · Jan 3, 2006 – Mar 1, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Progenics Pharmaceuticals Inc.